๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Outcome of ICU treatment in invasive aspergillosis

โœ Scribed by J. J. W. M. Janssen; R. J. M. Strack van Schijndel; E. H. van der Poest Clement; G. J. Ossenkoppele; L. G. Thijs; P. C. Huijgens

Book ID
105285183
Publisher
Springer
Year
1996
Tongue
English
Weight
722 KB
Volume
22
Category
Article
ISSN
1432-1238

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Changes in causes of death over time aft
Changes in causes of death over time after treatment for invasive aspergillosis
โœ John R. Wingard; Patricia Ribaud; Haran T. Schlamm; Raoul Herbrecht ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB

## Abstract ## BACKGROUND Assessment of response to invasive aspergillosis (IA) therapy has been challenging in treatment trials. ## METHODS The causes of death over 12 weeks were categorized prospectively by a blinded data review committee using a priori defined criteria in participants in a ra

Itraconazole added to a lipid formulatio
Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis
โœ Dimitrios P. Kontoyiannis; Maha Boktour; Hend Hanna; Harrys A. Torres; Ray Hache ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB

## Abstract ## BACKGROUND Invasive aspergillosis (IA) is associated with poor outcome in patients with hematologic malignancy treated with amphotericin B (AMB)โ€based therapy. Itraconazole (ITC), a triazole with activity against __Aspergillus__, has been used in combination with AMB or lipid formul